References
- Cronin KA, Lake AJ, Scott S, et al. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics. Cancer. 2018;124(13):2785–2800.
- Swetter SM, Tsao H, Bichakjian CK, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2019;80(1):208–250.
- Luke JJ, Flaherty KT, Ribas A, et al. Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol. 2017;14(8):463–482.
- Dummer R, Hauschild A, Lindenblatt N, et al. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v126–v132.
- Sealy RC, Hyde JS, Felix CC, et al. Novel free radicals in synthetic and natural pheomelanins: distinction between dopa melanins and cysteinyldopa melanins by ESR spectroscopy. Proc Natl Acad Sci USA. 1982;79(9):2885–2889.
- Prota G. Recent advances in the chemistry of melanogenesis in mammals. J Invest Dermatol. 1980;75(1):122–127.
- Hearing VJ. Determination of melanin synthetic pathways. J Invest Dermatol. 2011;131(E1):E8–E11.
- Godechal Q, Gallez B. The contribution of electron paramagnetic resonance to melanoma research. J Skin Cancer. 2011;2011:273280.
- Godechal Q, Defresne F, Danhier P, et al. Assessment of melanoma extent and melanoma metastases invasion using electron paramagnetic resonance and bioluminescence imaging. Contrast Media Mol Imaging. 2011;6(4):282–288.
- Godechal Q, Leveque P, Marot L, et al. Optimization of electron paramagnetic resonance imaging for visualization of human skin melanoma in various stages of invasion. Exp Dermatol. 2012;21(5):341–346.
- Godechal Q, Ghanem GE, Cook MG, et al. Electron paramagnetic resonance spectrometry and imaging in melanomas: comparison between pigmented and nonpigmented human malignant melanomas. Mol Imaging. 2013;12(4):218–223.
- Cesareo E, Korkina L, D’Errico G, et al. An endogenous electron spin resonance (ESR) signal discriminates nevi from melanomas in human specimens: a step forward in its diagnostic application. PLoS One. 2012;7(11):e48849.
- Nakagawa K, Minakawa S, Sawamura D, et al. Characterization of melanin radicals in paraffin-embedded malignant melanoma and nevus pigmentosus using X-band EPR and EPR imaging. Anal Sci. 2017;33(12):1357–1361.
- Vanea E, Charlier N, Dewever J, et al. Molecular electron paramagnetic resonance imaging of melanin in melanomas: a proof-of-concept. NMR Biomed. 2008;21(3):296–300.
- Swartz HM, Williams BB, Zaki BI, et al. Clinical EPR: unique opportunities and some challenges. Acad Radiol. 2014;21(2):197–206.
- Swartz HM, Williams BB, Hou H, et al. Direct and repeated clinical measurements of pO2 for enhancing cancer therapy and other applications. Adv Exp Med Biol. 2016;923:95–104.
- Nilges MJ, Walczak T, Swartz HM. 1 GHz in vivo ESR spectrometer operating with a surface probe. Phys Med. 1989;2:195–201.
- Watts KP, Fairchild RG, Slatkin DN, et al. Melanin content of hamster tissues, human tissues, and various melanomas. Cancer Res. 1981;41(2):467–472.